NCT00002405View on ClinicalTrials.gov

A Study of Amprenavir in HIV-Infected Patients

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Amprenavir

Trial Locations (1)

277093398

Glaxo Wellcome Inc, Research Triangle Park

Sponsors

Lead Sponsor

Glaxo Wellcome
All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY

NCT00002405 - A Study of Amprenavir in HIV-Infected Patients | Biotech Hunter | Biotech Hunter